Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MAIA stock hub

MAIA Biotechnology, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

MAIAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
80.1M
NYSEAMERICAN
Market data

Live price

Current market quote for this ticker.

Current price
MAIA
In the news

Latest news · MAIA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-745.2
P25 -105.6P50 -46.5P75 -3.1
ROIC-504.7
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All MAIA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
154
Groups with data
11
Currency
USD
Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001878313
Company name
MAIA Biotechnology, Inc.
Country
United States
Country code
US
Cusip
552641102
Employees
13
Employees Change
-5%
Employees Change Percent
-27.78
Enterprise value
$71.4M
Exchange
NYSEAMERICAN
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2022-07-28
Isin
US5526411021
Last refreshed
2026-05-10
Market cap
$80.1M
Market cap category
Micro-Cap
Price
$1.32
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
MAIA
Website
https://maiabiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

2
MetricValue
Earnings Yield
-27.97%
P/B ratio
21.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-22.4M
Net Income Growth Years
1%
Profit Per Employee
$-1.7M
ROA
-152.8
Roa5y
-113.7
ROCE
-627.4
ROE
-745.2
Roe5y
-566.5
ROIC
-504.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
-32.33%
Cagr3y
-22.53%
EPS Growth Quarters
1
EPS Growth Years
4
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Assets
$9.7M
Cash
$8.7M
Current Assets
$9.7M
Current Liabilities
$5.8M
Equity
$2.4M
Liabilities
$7.3M
Long Term Assets
$2,800
Long Term Liabilities
$1.5M
Net Cash
$8.7M
Net Cash By Market Cap
$10.81
Net Cash Growth
-9.82%
Net Debt Equity
$-3.64
Tangible Book Value
$2.4M
Tangible Book Value Per Share
$0.06
WACC
5.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
1.66
Net Working Capital
$-4.8M
Quick ratio
1.48
Working Capital
$3.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-44.68%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-32.31%
200-day SMA
1.54
3Y total return
-53.52%
50-day SMA
1.42
50-day SMA vs 200-day SMA
50under200
All Time High
9.64
All Time High Change
-86.31%
All Time High Date
2022-08-01
All Time Low
0.82
All Time Low Change
60.98%
All Time Low Date
2023-12-11
ATR
0.1
Beta
0.23
Beta1y
1.74
Beta2y
1.26
Ch YTD
-13.73
High
1.35
High52
3.19
High52 Date
2026-01-28
High52ch
-58.62%
Low
1.26
Low52
0.87
Low52 Date
2025-11-20
Low52ch
51.72%
Ma50ch
-6.98%
Price vs 200-day SMA
-14.06%
RSI
46.4
RSI Monthly
41.35
RSI Weekly
43.82
Sharpe ratio
-0.03x
Sortino ratio
0.03
Total Return
-44.68%
Tr YTD
-13.73
Tr1m
10%
Tr1w
-1.49%
Tr3m
-32.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Earnings EPS Estimate
$-0.18
Operating Income
$-24.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
55,623,106%
Float Percent
91.68%
Shares Insiders
8.27%
Shares Institutions
4.15%
Shares Out
60,671,491
Shares Qo Q
12.02%
Shares Yo Y
44.68%
Short Float
5.1%
Short Ratio
3.76
Short Shares
4.67

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

45
MetricValue
Average Volume
636,671.6x
Bv Per Share
0.06
Ch1m
10
Ch1w
-1.49
Ch1y
-32.31
Ch3m
-32.99
Ch3y
-53.52
Ch6m
17.86
Change
0.76%
Change From Open
1.54
Close
1.31
Days Gap
-0.76
Dollar Volume
403,233.6
Earnings Date
2026-05-22
Earnings Time
amc
EBIT
$-24.3M
EPS
$-0.7
F Score
1
Financing CF
17,906,547
Fiscal Year End
December
Founded
2,018
Ipr
-73.6
Iprfo
-67.8
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-23
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-23
Ma150
1.52
Ma150ch
-13.21%
Ma20
1.33
Ma20ch
-1.05%
Net CF
-943,267
Next Earnings Date
2026-05-22
Open
1.3
Optionable
No
Position In Range
66.67
Price Date
2026-05-08
Ptbv Ratio
33.71
Relative Volume
0.48x
Share Based Comp
2,631,652
Tr6m
17.86%
Us State
Illinois
Volume
305,480
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does MAIA pay a dividend?

Capital-return profile for this ticker.

Performance

MAIA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-32.3%
S&P 500 1Y: n/a
3Y total return
-53.5%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns MAIA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+4.2%
Float: +91.7% of shares outstanding
Insider ownership
+8.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+5.1%
3.8 days to cover
Y/Y dilution
+44.7%
Negative means the company is buying back shares.
Technical

MAIA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.4
Neutral momentum band
Price vs 200-day MA
-14.1%
50/200-day relationship not available
Beta (5Y)
0.23
Less volatile than the market
Sharpe ratio
-0.03
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About MAIA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MAIA stock rating?

MAIA Biotechnology, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MAIA analysis?

The full report lives at /stocks/MAIA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MAIA?

The latest report frames MAIA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MAIA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.